Back
Return
Biography
Prof. Peyman Adibi
Dr. Peyman Adibi
IsfahanUniversity of medical sciences, Iran

Doctor


Email:adibi@med.mui.ac.ir


Qualifications
Medical school and internship (7 yrs.): Isfahan University of medical sciences
Internal medicine residency (4 yrs.): Isfahan University of medical sciences

Gastroenterology fellowship (2 yrs.): Shahid Beheshti University of medical sciences


Publications (Selected)
  1. Hepatitis E virus in Isfahan Province: a population-based study.Int J Infect Dis. 2009; 13(1):67-71.
  2. HAV in Isfahan province: a population-based study. Trop Gastroenterol 2008; 29(3):160-2.
  3. Metabolic syndrome in schizophrenia patients.Ir J Diab Lipid 2008; 7(4):419-24.
  4. Evidence-based medicine (EBM) for undergraduate medical students. Ann Acad Med Singapore. 2008; 37(9):764-8.
  5. Level of oxidative stress markers among physicians in a medical residency program.Arch Environ Occup Health. 2008; 63(3):154-8.
  6. POISE trial quality control. Lancet. 2008 Sep 27; 372(9644):1147.
  7. Attitudes towards premarital screening for hepatitis B virus infection in Iran.J Med Screen. 2007;14(1):43-5.
  8. Prediction of coronary atherosclerotic disease with liver transaminase level.Liver Int. 2007; 27(7):895-900.
  9. Bowel habit reference values and abnormalities in young Iranian healthy adults.Dig Dis Sci. 2007; 52(8):1810-3.
  10. Population-based platelet reference values for an Iranian population.Int J Lab Hematol. 2007; 29(3):195-9.
  11. The Effects of Clinical Rounds on Patients in Internal Wards of Hospitals Affiliated to Isfahan University of Medical Sciences: The Viewpoints of Clinical care team.IJME 2007; 7(1):15-22.
  12. Comparing epinephrine injection with and without Argon plasma coagulation in bleeding peptic ulcers.Pajoohandeh 2007;11(54):351-6.
  13. Seroprevalence of hepatitis B in Nahavand, Islamic Republic of Iran.East Mediterr Health J. 2006; 12(5):528-37.
  14. Hemochromatosis mutations in Iranians with hepatitis B virus infection.Clin Infect Dis. 2005; 40(3):e19-21.
  15. Silent ischemia in type I diabetic patients. ARYA Journal, 2005, 1(2): 89-93.
  16. Lamivudine or Interferon alpha? this is the problem. Hepatitis Monthly 2004;4(6):9-12.
  17. Hepatitis C Virus in Iran: Epidemiology of an Emerging Infection. Archives of Iranian Medicine 2005;8(2):84-90.
  18. Effectiveness of hepatitis B vaccination in children of chronic hepatitis B mothers.Saudi Med J. 2004; 25(10):1414-8.
  19. An economic analysis of premarriage prevention of hepatitis B transmission in Iran. BMC Infect Dis. 2004; 4:31.
  20. Frequency of HFE gene mutations in Iranian beta-thalassaemia minor patients. Eur J Haematol. 2003; 71(6):408-11.
  21. A Multistage Group Education for Hepatitis B patients in Iran. Iranian Journal of Medical Education 2002; 4: 2-8.
  22. Interns' view about basic medical sciences: their knowledge and attitude to national comprehensive exam and basic medical courses in Isfahan university of medical sciences. IJME 2000; 1(1):19-23.
  23. The study of glycolysis enzymes in thalasemia. Ofog-e-Danesh 2006;11(1):38-44.
  24. The Clinical Rounds on Patients’ Bedside in Internal Ward from Patients’ Viewpoints. IJME 2006; 6(1):15-21.
  25. Viewpoints of Supervisors about the Problems in the Process of Dissertations for General Medicine Program; Isfahan University of Medical Sciences. 2003;3( 1):24-31.
  26. Using Case Discussion for Resident Training. IJME 2003;3(1):7-13.
  27. Early Clinical Encounter: Report of an Intervention. IJME 2002;2(1):5-11.
  28. Reference values of red blood cell indices: a study on 170000cases. Research in medical sciences 2002; 25(2):9-15.
  29. A study on Cesarean section and its ethiologies in Iran. Hakim medical journal 2000; 3(2):23-7.